Am. J. Respir. Crit. Care Med., Volume 157, Number 6, June 1998, 1764-1769

Circulating Immunoreactive Interleukin-6 in Cystic Fibrosis

LISETTE S. NIXON, BERNARD YUNG, SCOTT C. BELL, J. STUART ELBORN, and DENNIS J. SHALE

Section of Respiratory Medicine, University of Wales College of Medicine, Academic Centre, Llandough Hospital NHS Trust, Penarth, South Glamorgan, United Kingdom

We measured circulating and sputum-sol concentrations of interleukin-6 (IL-6), tumor necrosis factor- (TNF-), neutrophil elastase-₁-antiproteinase complex (NEAPC), and C-reactive protein (CRP) in an exacerbation, after antibiotic treatment, and in clinically stable patients with cystic fibrosis and chronic pulmonary infection with Pseudomonas aeruginosa. The aim was to determine the compartmental patterns of a proinflammatory and anti-inflammatory cytokine compared with other markers of inflammatory activity in cystic fibrosis. IL-6, NEAPC, CRP, and absolute neutrophil count were reduced after antibiotic treatment, p < 0.01. IL-6 and CRP concentrations were greater, p = 0.007, and p = 0.01, respectively, in a stable group of patients compared with those at the end of an exacerbation. IL-6 and CRP concentrations were related (r = 0.836, p < 0.0001), and both were greater than in matched control subjects (p < 0.001) at all times studied. Sputum-sol concentrations of IL-6 after treatment were positively related to FEV₁ and FVC and inversely related to concentrations of neutrophil elastase. The separation between patients and healthy subjects, and the reduction of IL-6 after antibiotic treatment indicates it could be used as a marker of inflammation, but its relationship to other markers depends on the compartment in which it is measured.

This article has been cited by other articles:

				V. Dufresne, C. Knoop, A. Van Muylem, A. Malfroot, M. Lamotte, C. Opdekamp, G. Deboeck, M. Cassart, B. Stallenberg, G. Casimir, et al. Effect of Systemic Inflammation on Inspiratory and Limb Muscle Strength and Bulk in Cystic Fibrosis Am. J. Respir. Crit. Care Med., July 15, 2009; 180(2): 153 - 158. [Abstract] [Full Text] [PDF]

				M. T. Saavedra, G. J. Hughes, L. A. Sanders, M. Carr, D. M. Rodman, C. D. Coldren, M. W. Geraci, S. D. Sagel, F. J. Accurso, J. West, et al. Circulating RNA Transcripts Identify Therapeutic Response in Cystic Fibrosis Lung Disease Am. J. Respir. Crit. Care Med., November 1, 2008; 178(9): 929 - 938. [Abstract] [Full Text] [PDF]

				S. D. Sagel, J. F. Chmiel, and M. W. Konstan Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease Proceedings of the ATS, August 1, 2007; 4(4): 406 - 417. [Abstract] [Full Text] [PDF]

				A. A. IONESCU, L. S. NIXON, S. LUZIO, V. LEWIS-JENKINS, W. D. EVANS, M. D. STONE, D. R. OWENS, P. A. ROUTLEDGE, and D. J. SHALE Pulmonary Function, Body Composition, and Protein Catabolism in Adults with Cystic Fibrosis Am. J. Respir. Crit. Care Med., February 15, 2002; 165(4): 495 - 500. [Abstract] [Full Text] [PDF]

				R. T. M. Boudreau, R. Garduno, and T.-J. Lin Protein Phosphatase 2A and Protein Kinase Calpha Are Physically Associated and Are Involved in Pseudomonas aeruginosa-induced Interleukin 6 Production by Mast Cells J. Biol. Chem., February 8, 2002; 277(7): 5322 - 5329. [Abstract] [Full Text] [PDF]

				A. A. EID, A. A. IONESCU, L. S. NIXON, V. LEWIS-JENKINS, S. B. MATTHEWS, T. L. GRIFFITHS, and D. J. SHALE Inflammatory Response and Body Composition in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1414 - 1418. [Abstract] [Full Text] [PDF]

				A. A. IONESCU, A.-A. IONESCU, N. PAYNE, I. OBIETA-FRESNEDO, A. G. FRASER, and D. J. SHALE Subclinical Right Ventricular Dysfunction in Cystic Fibrosis . A Study Using Tissue Doppler Echocardiography Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1212 - 1218. [Abstract] [Full Text]

				R. M. ARIS, A. R. STEPHENS, D. A. ONTJES, A. DENENE BLACKWOOD, R. K. LARK, M. B. HENSLER, I. P. NEURINGER, and G. E. LESTER Adverse Alterations in Bone Metabolism Are Associated with Lung Infection in Adults with Cystic Fibrosis Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1674 - 1678. [Abstract] [Full Text]

				A. A. IONESCU, L. S. NIXON, W. D. EVANS, M. D. STONE, V. LEWIS-JENKINS, K. CHATHAM, and D. J. SHALE Bone Density, Body Composition, and Inflammatory Status in Cystic Fibrosis Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 789 - 794. [Abstract] [Full Text]

				D. L. Clemans, R. J. Bauer, J. A. Hanson, M. V. Hobbs, J. W. St. Geme III, C. F. Marrs, and J. R. Gilsdorf Induction of Proinflammatory Cytokines from Human Respiratory Epithelial Cells after Stimulation by Nontypeable Haemophilus influenzae Infect. Immun., August 1, 2000; 68(8): 4430 - 4440. [Abstract] [Full Text] [PDF]

				A. M. van HEECKEREN, J. TSCHEIKUNA, R. W. WALENGA, M. W. KONSTAN, P. B. DAVIS, B. EROKWU, M. A. HAXHIU, and T. W. FERKOL Effect of Pseudomonas Infection on Weight Loss, Lung Mechanics, and Cytokines in Mice Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 271 - 279. [Abstract] [Full Text]